Managament simply need to be transparent, there is no...

Managament simply need to be transparent, there is no information available to investors on the expected retail price of these drugs. There is no information available about how much stock they are getting for their initial $400k order. This is replicated across pretty much every initiative they have on the boil. The only insight investors get is to retrospecitively look at the success or failure of deals through financial reports.

If they were able to include anticipated revenue figures from the deals then the market could assess them, for now it remains skeptical based on past experience.